Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ethibloc

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
IntroductionDespite the long experience of radiologists, pathologists and orthopaedists with aneurysmal bone cysts (ABC), there… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
2005
2005
The effects of percutaneous Ethibloc (Ethicon/Johnson & Johnson, St-Stevens-Woluwe, Belgium) injection into primary aneurysmal… Expand
Highly Cited
2004
Highly Cited
2004
A 4-year-old boy developed progressive neck pain and an expansile osteogenic lesion of C2; the diagnosis was an aneurysmal bone… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
Benign bone cysts often require treatment in order to prevent pathological fracture. We report preliminary experience with… Expand
  • table 1
  • figure I
Review
2003
Review
2003
ObjectiveEthibloc is a fibrogenic and thrombogenic agent recently proposed for the treatment of bone cysts. The purpose of this… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2001
Highly Cited
2001
Abstract Purpose: To assess the efficacy and long-term results of Ethibloc treatment in aneurysmal bone cysts (ABC). Methods… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2000
Highly Cited
2000
Abstract Objective. To investigate whether the injection of Ethibloc into aneurysmal bone cysts can be an effective treatment… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Review
1999
Review
1999
Abstract Terminology regarding the vascular lesions of the soft tissues remains confusing. A single classification is necessary… Expand
  • table 2
Highly Cited
1997
Highly Cited
1997
Silymarin (SIL), a standardized plant extract containing about 60% polyphenole silibinin, is used as a hepatoprotective agent… Expand
Highly Cited
1991
Highly Cited
1991
Thirty-eight children with soft-tissue venous malformations (VMs) were treated with percutaneous injection of a new fibrosing… Expand